INDIVUMED
LIVE

Serial Number

78349885

Owner

Indivumed GmbH

Attorney

Tristram R. Fall, III

Filing Date

Jan 9, 2004

Add to watchlist:

No watchlists yet
View on USPTO

INDIVUMED Trademark

Serial Number: 78349885 • Registration: 3007328

INDIVUMED is a trademark filed by Indivumed GmbH on January 9, 2004. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Indivumed GmbH (5 trademarks)

Falkenried 88

Entity Type: 27

Trademark Details

Filing Date

January 9, 2004

Registration Date

October 18, 2005

Published for Opposition

July 26, 2005

Goods & Services

[ Scientific apparatus and instruments, namely, tissue punches, punch biopsy, biopsy needles, apparatus for collecting biological samples such as tissue, cuts, blood, serum, plasma, ascites, cerebrospinal fluid, urine or stool; electronic apparatus and instruments for scientific laboratory research, namely, electronic analyzers and analyzers for the qualitative and quantitative recognition of samples and identification of the sample type; scientific electronic apparatus for the typing of tissues and tissue cuts; scientific electronic apparatus for collecting biological samples such as tissue, cuts, blood, serum, plasma, ascites, cerebrospinal fluid, urine or stool; scientific electronic apparatus for recording, transmission and reproduction of data; magnetic data carriers; data-processors and computers ]

Scientific research; design and development of new technology for others in the field of cancer [ , metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial design analysis and ] research services; [ design and development of computer hardware and software relating to programs for data processing; ] scientific research for medical purposes relating to molecular biological, immunological and histological laboratory, in particular research and development work in the field of human medicine [ and veterinary medicine ] diagnosis and treatment [ ; medical laboratories, namely, typing of tissues and tissue cuts, in particular by means of molecular biological, immunological, genetic engineering and histological methods; laboratory blood testing services ]

[ (( Medical testing in connection with the treatment of individuals; [ X-ray services; ] medical clinic services [; medicinal counseling ] )) ]

[ Pharmaceutical and veterinary preparations, namely, medicines for humans and animals for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample material, namely, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ((ascites, )) cerebrospinal fluid, human and animal urine and human and animal stool; test kits for human and animal sample material, namely, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic aids and therapeutic agents, in particular produced using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for clinical and medical and laboratory use ]

Filing History

NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
Jan 18, 2026 NP89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jan 18, 2026 RNL2
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Jan 18, 2026 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Jan 18, 2026 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 18, 2026 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 13, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 18, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 2, 2015 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 2, 2015 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 2, 2015 89AG
TEAS SECTION 8 & 9 RECEIVED
Sep 30, 2015 E89R
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
May 10, 2012 NAS8
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
May 10, 2012 NA15
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
May 10, 2012 8.PR
REGISTERED - SEC. 15 ACKNOWLEDGED
May 10, 2012 15AK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 10, 2012 APRE
REGISTERED - SEC. 8 (6-YR) FILED
Mar 22, 2012 8.AF
TEAS SECTION 15 RECEIVED
Mar 22, 2012 E15R
TEAS SECTION 8 RECEIVED
Mar 22, 2012 ES8R
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2005 R.PR
PUBLISHED FOR OPPOSITION
Jul 26, 2005 PUBO
NOTICE OF PUBLICATION
Jul 6, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 31, 2005 PREV
ASSIGNED TO LIE
Mar 11, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
Mar 7, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 7, 2005 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 7, 2005 ZZZX
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 11, 2005 PREV
ASSIGNED TO LIE
Feb 4, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
Feb 2, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 2, 2005 CNEA
AMENDMENT FROM APPLICANT ENTERED
Jan 13, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2004 TROA
NON-FINAL ACTION E-MAILED
Jun 18, 2004 GNRT
ASSIGNED TO EXAMINER
Jun 15, 2004 DOCK
NEW APPLICATION ENTERED
Jan 14, 2004 NWAP